Nautilus Biotechnology (NASDAQ:NAUT) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.15) by 26.67 percent. This is a 8.33 percent increase over losses of $(0.12) per share from the same period last year.
Samsung Expects 35% Operating Profit Dip In Q4 Amid Semiconductor Price Recovery
Samsung's operating profit for Q4 2023 is expected to be 2.8 trillion South Korean won ($2.13 billion), a 35% decrease from the same quarter the previous year.
